Chest Medicine (all articles)
RCT: A 2-week interruption in methotrexate treatment doubles the antibody response to a COVID-19 booster vaccine.
29 Jun, 2022 | 12:10h | UTCNews Releases:
Interrupting immune-suppressing treatment can boost COVID vaccine response – Imperial College London
Commentaries:
Commentary on Twitter
NEW Research—2-week interruption of methotrexate treatment for people w/ immune-mediated inflammatory diseases = enhanced boosting of antibody responses after #COVID19 vaccination
From Prof Abhishek Abhishek & colleagues https://t.co/y14pUEaB5X pic.twitter.com/pLvaXjJzoz
— The Lancet Respiratory Medicine (@LancetRespirMed) June 28, 2022
Perspective | Fast-evolving COVID variants complicate vaccine updates.
29 Jun, 2022 | 12:01h | UTCFast-evolving COVID variants complicate vaccine updates – Nature
Retrospective Cohort Study: Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation.
29 Jun, 2022 | 11:54h | UTC
An analysis of SARS-CoV-2 vaccine reactogenicity: variation by type, dose, and history, severity, and recency of prior SARS-CoV-2 infection.
29 Jun, 2022 | 11:52h | UTC
Systematic Review: Exercise versus airway clearance techniques for people with cystic fibrosis.
29 Jun, 2022 | 11:10h | UTCExercise versus airway clearance techniques for people with cystic fibrosis – Cochrane Library
Summary: Exercise versus airway clearance for people with cystic fibrosis – Cochrane Library
Brief Review: Noninvasive respiratory support in intensive care medicine.
29 Jun, 2022 | 11:06h | UTCNoninvasive respiratory support in intensive care medicine – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Noninvasive respiratory support in #ICU
? hypercapnic failure
?respiratory failure due to acute cardiogenic pulmonary edema
⚠️ weaning or extubation in high-risk or obese pts
? de novo hypoxemic respiratory failure if careful pt selection/monitoring
? https://t.co/pTdzEEW2Xf pic.twitter.com/S3oEpUppNC— Intensive Care Medicine (@yourICM) June 28, 2022
Systematic Review: Trastuzumab Deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies.
29 Jun, 2022 | 10:59h | UTC
Guideline: Sleep-related breathing disorders in adults.
28 Jun, 2022 | 11:21h | UTCPartial update of the German S3 Guideline Sleep-Related Breathing Disorders in Adults – Somnologie
RCT: Two-day vs. seven-day course of levofloxacin in acute COPD exacerbation.
28 Jun, 2022 | 11:19h | UTCCommentary: Antibiotics in COPD Exacerbations – 2 days vs 7 days – RebelEM
Review: Primary graft dysfunction after clinical lung transplantation.
28 Jun, 2022 | 10:37h | UTC
[Press Release – not published yet]: RCT: Sanofi-GSK report its vaccine targeted against ancestral and Beta strains had an overall efficacy of 72% against the Omicron variant.
27 Jun, 2022 | 11:52h | UTCPress Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine – Sanofi
Commentaries: Bivalent COVID Vax Gets Phase III Win Against Omicron, Companies Say — Sanofi, GSK boast of 72% efficacy against Omicron variant – MedPage Today (free registration required)
Perspective | What Omicron’s BA.4 and BA.5 variants mean for the pandemic.
27 Jun, 2022 | 11:48h | UTCWhat Omicron’s BA.4 and BA.5 variants mean for the pandemic – Nature
M-A: The role of resistance exercise training for improving cardiorespiratory fitness in healthy older adults.
27 Jun, 2022 | 11:42h | UTC
Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study.
27 Jun, 2022 | 11:29h | UTC
Commentary on Twitter
Can we accurately predict who gets postoperative pulmonary complications (PPCs) following abdominal surgery?
In our first ever @LancetDigitalH paper, @STARSurgUK @TASMANCollab use the #RECON dataset to evaluate existing risk prediction scores
Read here: https://t.co/oJEpR1aL1S pic.twitter.com/XPRjy6iyrS
— STARSurg (@STARSurgUK) June 22, 2022
Phase 2a RCT: Vaccine efficacy in adults in a respiratory syncytial virus challenge study.
27 Jun, 2022 | 11:21h | UTCVaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study -New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Challenge Study Shows Efficacy of RSV Vaccine in Healthy Adults – HealthDay
Commentary on Twitter
A human challenge model was used to assess the safety and immunogenicity of an RSV prefusion F protein-based vaccine against RSV infection. The vaccine construct has advanced to further clinical testing.https://t.co/KKfqzCyyGF pic.twitter.com/H7i7F8KLmv
— NEJM (@NEJM) June 22, 2022
Systematic Review: Short‐acting inhaled bronchodilators for cystic fibrosis.
27 Jun, 2022 | 11:15h | UTCShort‐acting inhaled bronchodilators for cystic fibrosis – Cochrane Library
Summary: Short-acting inhaled bronchodilators for cystic fibrosis – Cochrane Library
Cohort Study: COVID-19 trajectories among 57 million adults in England.
24 Jun, 2022 | 11:34h | UTCNews Release: Most comprehensive analysis of COVID-19 data reveals previously unattributed deaths – Health Data Research UK
Commentary from one of the authors on Twitter (thread – click for more)
? COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
Proud to share this work with @johanhilge @SpirosDenaxas @BHFDataScience @HDR_UK + team in @LancetDigitalHhttps://t.co/DY96ClN0c3
?
— Chris Tomlinson (@tomlincr) June 9, 2022
Position Paper: Teleconsultation in respiratory medicine.
24 Jun, 2022 | 11:11h | UTC
Review: The physiological basis of pulmonary arterial hypertension.
24 Jun, 2022 | 10:45h | UTCThe physiological basis of pulmonary arterial hypertension – European Respiratory Journal
Study Commentary | How FAST can you spot a pneumothorax? breaking down a surprising result comparing ultrasound and chest radiograph in traumatic pneumothorax.
24 Jun, 2022 | 10:39h | UTCOriginal Study: Not so FAST—Chest ultrasound underdiagnoses traumatic pneumothorax – Journal of Trauma and Acute Care Surgery (link to abstract – $ for full-text)
AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.
23 Jun, 2022 | 13:03h | UTCNews Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association
Ivermectin for COVID-19 Cochrane review update: 11 trials and no evidence of benefit shown.
23 Jun, 2022 | 10:38h | UTCNews Release: Ivermectin for COVID-19 review update: 11 trials and no evidence of benefit shown – Liverpool School of Tropical Medicine
Original Article: Ivermectin for preventing and treating COVID‐19 – Cochrane Library
Summary: Ivermectin for preventing and treating COVID-19 – Cochrane Library
Systematic Review: SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19.
23 Jun, 2022 | 10:37h | UTCSARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19 – Cochrane Library
ASA and APSF statement on perioperative testing for the COVID-19 virus.
22 Jun, 2022 | 12:19h | UTCCommentary: ASA, APST Update Perioperative SARS-CoV-2 Testing Recommendations – HealthDay
Related:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Review: Sex differences in sequelae from COVID-19 infection and in long COVID syndrome.
22 Jun, 2022 | 12:06h | UTCCommentary: Women more likely to have long COVID, different symptom profile – CIDRAP